NCT00728663 2019-05-14
Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer
Swiss Cancer Institute
Phase 2 Completed
Clinical Trials
5 trialsNCT00350025 2017-03-31
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
Fox Chase Cancer Center
Phase 2 Completed
NCT00661492 2016-12-09
Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
US Oncology Research
Phase 2 Completed
NCT00645593 2016-05-23
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00448097 2016-03-17
Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy
The Methodist Hospital Research Institute
Phase 2 Terminated